Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 285
Gene Symbol: ANGPT2
ANGPT2
CUI: C0039483
Disease: Giant Cell Arteritis
Giant Cell Arteritis
0.010 AlteredExpression BEFREE High angiopoietin-2 levels associate with arterial inflammation and long-term glucocorticoid requirement in polymyalgia rheumatica. 31292652

2020

Entrez Id: 3627
Gene Symbol: CXCL10
CXCL10
CUI: C0039483
Disease: Giant Cell Arteritis
Giant Cell Arteritis
0.010 Biomarker BEFREE Significant differences in the levels of IL-1RA, IL-10, GM-CSF, eotaxin, and IP-10 were observed between the HD-TAK and HD-GCA groups. 30679579

2019

Entrez Id: 386653
Gene Symbol: IL31
IL31
CUI: C0039483
Disease: Giant Cell Arteritis
Giant Cell Arteritis
0.010 Biomarker BEFREE Importantly, we show for the first time significantly changed levels of MARCO, alpha-fetoprotein, protein C, resistin, TNC, TNF RI, M-CSF, IL-18, and IL-31 in GCA versus HBDs. 30143961

2019

Entrez Id: 5806
Gene Symbol: PTX3
PTX3
CUI: C0039483
Disease: Giant Cell Arteritis
Giant Cell Arteritis
0.010 AlteredExpression BEFREE Anti-angiogenic factor (Angiostatin, Endostatin, PTX3) serum levels were significantly higher in both GCA and TAK patients compared to NC. 31573481

2019

Entrez Id: 284
Gene Symbol: ANGPT1
ANGPT1
CUI: C0039483
Disease: Giant Cell Arteritis
Giant Cell Arteritis
0.010 Biomarker BEFREE To investigate serum levels of a panel of angiogenic inducers (VEGF, FGF-2, Angiopoietin 1, -2, soluble VCAM-1) and inhibitors (angiostatin, endostatin, pentraxin-3) in patients with giant cell arteritis (GCA) and Takayasu's arteritis (TAK), in order to gain further insights into the molecular mechanisms driving angiogenesis dysregulation in large-vessel vasculitis (LVV). 31573481

2019

Entrez Id: 1040
Gene Symbol: CDS1
CDS1
CUI: C0039483
Disease: Giant Cell Arteritis
Giant Cell Arteritis
0.010 Biomarker BEFREE Since CDS can mimic meningitis or giant-cell arteritis, neurologists should be aware of this entity. 31127531

2019

Entrez Id: 7869
Gene Symbol: SEMA3B
SEMA3B
CUI: C0039483
Disease: Giant Cell Arteritis
Giant Cell Arteritis
0.010 Biomarker BEFREE However, as the host gene of miR-6872, the roles of SEMA3B, antisense lncRNA SEMA3B-AS1, and miR-6872 in gastric cardia adenocarcinoma (GCA) tumorigenesis have not been clarified. 30656427

2019

Entrez Id: 2247
Gene Symbol: FGF2
FGF2
CUI: C0039483
Disease: Giant Cell Arteritis
Giant Cell Arteritis
0.010 Biomarker BEFREE Among numerous cytokines and chemokines analyzed, only FGF-2 could be used together with age at diagnosis to differentiate TAK and GCA. 30679579

2019

Entrez Id: 7852
Gene Symbol: CXCR4
CXCR4
CUI: C0039483
Disease: Giant Cell Arteritis
Giant Cell Arteritis
0.010 GeneticVariation BEFREE A 0.64-fold decreased risk of GCA is associated with the CXCR4 rs6430612 CT genotype compared with the CC genotype (P = 0.002). 30900102

2019

Entrez Id: 102465526
Gene Symbol: MIR6872
MIR6872
CUI: C0039483
Disease: Giant Cell Arteritis
Giant Cell Arteritis
0.010 Biomarker BEFREE However, as the host gene of miR-6872, the roles of SEMA3B, antisense lncRNA SEMA3B-AS1, and miR-6872 in gastric cardia adenocarcinoma (GCA) tumorigenesis have not been clarified. 30656427

2019

Entrez Id: 25937
Gene Symbol: WWTR1
WWTR1
CUI: C0039483
Disease: Giant Cell Arteritis
Giant Cell Arteritis
0.010 AlteredExpression BEFREE Expression of WWTR1 has a significant inverse correlation with cumulative survival of GCA patients (p < 0.01). 30976198

2019

Entrez Id: 2350
Gene Symbol: FOLR2
FOLR2
CUI: C0039483
Disease: Giant Cell Arteritis
Giant Cell Arteritis
0.010 Biomarker BEFREE Formalin-fixed and paraffin-embedded temporal artery biopsies from GCA and normal controls were stained with Hematoxylin and Eosin to review tissue histology and identify pathognomonic features.Immunohistochemistry was used to detect FRB, CD68 and CD3 expression. 30799840

2019

Entrez Id: 55034
Gene Symbol: MOCOS
MOCOS
CUI: C0039483
Disease: Giant Cell Arteritis
Giant Cell Arteritis
0.010 Biomarker BEFREE Baseline SF-36 PCS, MCS and domain scores were low, indicating impaired HRQOL related to GCA. 30786937

2019

Entrez Id: 80781
Gene Symbol: COL18A1
COL18A1
CUI: C0039483
Disease: Giant Cell Arteritis
Giant Cell Arteritis
0.010 AlteredExpression BEFREE Anti-angiogenic factor (Angiostatin, Endostatin, PTX3) serum levels were significantly higher in both GCA and TAK patients compared to NC. 31573481

2019

Entrez Id: 213
Gene Symbol: ALB
ALB
CUI: C0039483
Disease: Giant Cell Arteritis
Giant Cell Arteritis
0.010 AlteredExpression BEFREE The SCNSV group had lower serum levels of C-reactive protein at the time of GCA diagnosis and higher cerebrospinal fluid (CSF) levels of total protein (102 mg/dL vs. 38 mg/dL, <i>p</i> = .008) and albumin (66 mg/dL vs. 21 mg/dL, <i>p</i> = .008) at the time of SCNSV diagnosis. 31599690

2019

Entrez Id: 2258
Gene Symbol: FGF13
FGF13
CUI: C0039483
Disease: Giant Cell Arteritis
Giant Cell Arteritis
0.010 Biomarker BEFREE Among numerous cytokines and chemokines analyzed, only FGF-2 could be used together with age at diagnosis to differentiate TAK and GCA. 30679579

2019

Entrez Id: 4184
Gene Symbol: SMCP
SMCP
CUI: C0039483
Disease: Giant Cell Arteritis
Giant Cell Arteritis
0.010 Biomarker BEFREE Baseline SF-36 PCS, MCS and domain scores were low, indicating impaired HRQOL related to GCA. 30786937

2019

Entrez Id: 55906
Gene Symbol: ZC4H2
ZC4H2
CUI: C0039483
Disease: Giant Cell Arteritis
Giant Cell Arteritis
0.010 Biomarker BEFREE Baseline SF-36 PCS, MCS and domain scores were low, indicating impaired HRQOL related to GCA. 30786937

2019

Entrez Id: 6901
Gene Symbol: TAZ
TAZ
CUI: C0039483
Disease: Giant Cell Arteritis
Giant Cell Arteritis
0.010 Biomarker BEFREE To search for the biomarker for GCA metastasis, we here examined expression of the Hippo signaling effector WWTR1 (WW domain containing transcription regulator 1, commonly listed as TAZ) in tumor tissue samples from 214 GCA cases using the tissue microarray assay (TMA), and statistically analyzed association of the WWTR1 expression with metastasis-related pathological outcomes and cumulative survival of the GCA patients. 30976198

2019

Entrez Id: 43
Gene Symbol: ACHE
ACHE
CUI: C0039483
Disease: Giant Cell Arteritis
Giant Cell Arteritis
0.010 AlteredExpression BEFREE No AChE expression was observed outside the media smooth muscle cells (grade 0) in any of the biopsy-negative non-GCA patients. 31162030

2019

Entrez Id: 7412
Gene Symbol: VCAM1
VCAM1
CUI: C0039483
Disease: Giant Cell Arteritis
Giant Cell Arteritis
0.010 Biomarker BEFREE To investigate serum levels of a panel of angiogenic inducers (VEGF, FGF-2, Angiopoietin 1, -2, soluble VCAM-1) and inhibitors (angiostatin, endostatin, pentraxin-3) in patients with giant cell arteritis (GCA) and Takayasu's arteritis (TAK), in order to gain further insights into the molecular mechanisms driving angiogenesis dysregulation in large-vessel vasculitis (LVV). 31573481

2019

Entrez Id: 5289
Gene Symbol: PIK3C3
PIK3C3
CUI: C0039483
Disease: Giant Cell Arteritis
Giant Cell Arteritis
0.010 GeneticVariation BEFREE We observed that CXCR4 rs6430612, TERT rs10069690, and rs2853676 as well as VPS34 rs2162440 are significantly associated with GCA development. 30900102

2019

Entrez Id: 2993
Gene Symbol: GYPA
GYPA
CUI: C0039483
Disease: Giant Cell Arteritis
Giant Cell Arteritis
0.010 GeneticVariation BEFREE HTN/DM developed within 6 months of diagnosis in 9% of patients with AAV (6% in GPA, 21% in MPA, 3% in EGPA) and 6% of patients with GCA, p=0.15. 31498071

2019

Entrez Id: 7015
Gene Symbol: TERT
TERT
CUI: C0039483
Disease: Giant Cell Arteritis
Giant Cell Arteritis
0.010 GeneticVariation BEFREE We also detected a 2.17-fold increased OR for GCA that was associated with the TERT rs2853676 TT genotype (P = 2.6×10<sup>-6</sup>). 30900102

2019

Entrez Id: 1032
Gene Symbol: CDKN2D
CDKN2D
CUI: C0039483
Disease: Giant Cell Arteritis
Giant Cell Arteritis
0.010 AlteredExpression BEFREE The aims of this study were to investigate p40, p35, and p19 subunit expression in GCA lesions and their combinations to conform different cytokines, to assess the effect of glucocorticoid treatment on subunit expression, and to explore functional roles of p40 by culturing temporal artery sections with a neutralizing anti-human IL-12/IL-23p40 antibody. 29731755

2018